60444 Federal Register / Vol. 65, No. 197 / Wednesday, October 11, 2000 / Notices

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Agency for Toxic Substances and

Disease Registry

[ATSDR–162]

Availability of Draft Toxicological

Profiles

AGENCY: Agency for Toxic Substances

and Disease Registry (ATSDR),

Department of Health and Human

Services (HHS).

ACTION: Notice of availability.

SUMMARY: The Comprehensive

Environmental Response,

Compensation, and Liability Act of 1980

(CERCLA), as amended by the

Superfund Amendments and

Reauthorization Act of 1986 (SARA),

Section 104(i)(3) [42 U.S.C. 9604(i)(3)]

directs the Administrator of ATSDR to

prepare toxicological profiles of priority

hazardous substances and to revise and

publish each updated toxicological

profile as necessary. This notice

announces the availability of the 14th

set of toxicological profiles, which

consists of seven updated drafts,

prepared by ATSDR for review and

comment.

DATES: In order to be considered,

comments on these draft toxicological

profiles must be received on or before

February 23, 2001. Comments received

after the close of the public comment

period will be considered at the

discretion of ATSDR based upon what

is deemed to be in the best interest of

the general public.

ADDRESSES: Requests for copies of the

draft toxicological profiles should be

sent to the attention of Ms. Franchetta

Stephens, Division of Toxicology,

Agency for Toxic Substances and

Disease Registry, Mailstop E–29, 1600

Clifton Road, NE, Atlanta, Georgia

30333. Comments regarding the draft

toxicological profiles should be sent to

the attention of Dr. Ganga Choudhary,

Division of Toxicology, Agency for

Toxic Substances and Disease Registry,

Mailstop E–29, 1600 Clifton Road, NE,

Atlanta, Georgia 30333.

Requests for the draft toxicological

profiles must be in writing, and must

specifically identify the hazardous

substance(s) profile(s) you wish to

receive. ATSDR reserves the right to

provide only one copy of each profile

requested, free of charge. In case of

extended distribution delays, requestors

will be notified.

Written comments and other data

submitted in response to this notice and

the draft toxicological profiles should

bear the docket control number ATSDR–

162. Send one copy of all comments and

three copies of all supporting

documents to Dr. Ganga Choudhary at

the above stated address by the end of

the comment period. Because all public

comments regarding ATSDR

toxicological profiles are available for

public inspection, no confidential

business or other confidential

information should be submitted in

response to this notice.

FOR FURTHER INFORMATION CONTACT: Ms.

Franchetta Stephens, Division of

Toxicology, Agency for Toxic

Substances and Disease Registry,

Mailstop E–29, 1600 Clifton Road, NE,

Atlanta, Georgia 30333, telephone 1–

(800)447–1544 or (404)639–6345.

SUPPLEMENTARY INFORMATION: The

Superfund Amendments and

Reauthorization Act (SARA) (Pub. L.

99–499) amends the Comprehensive

Environmental Response,

Compensation, and Liability Act

(CERCLA or Superfund) (42 U.S.C. 9601

et seq.) by establishing certain

responsibilities for ATSDR and the

Environmental Protection Agency (EPA)

with regard to hazardous substances

which are most commonly found at

facilities on the CERCLA National

Priorities List (NPL). Among these

responsibilities is that the Administrator

of ATSDR prepare toxicological profiles

for substances included on the priority

lists of hazardous substances. These

lists identified 275 hazardous

substances that ATSDR and EPA

determined pose the most significant

potential threat to human health. The

availability of the revised priority list of

275 hazardous substances was

announced in the Federal Register on

October 21, 1999 (64 FR 56792). For

prior versions of the list of substances

see Federal Register notices dated April

17, 1987 (52 FR 12866); October 20,

1988 (53 FR 41280); October 26, 1989

(54 FR 43619); October 17, 1990 (55 FR

42067); October 17, 1991 (56 FR 52166);

October 28, 1992 (57 FR 48801);

February 28, 1994 (59 FR 9486); April

29, 1996 (61 FR 18744) and November

17, 1997 (62 FR 61332). [CERCLA also

requires ATSDR to assure the initiation

of a research program to fill data needs

associated with the substances.]

Section 104(i)(3) of CERCLA [42

U.S.C. 9604(i)(3)] outlines the content of

these profiles. Each profile will include

an examination, summary and

interpretation of available toxicological

information and epidemiologic

evaluations. This information and these

data are to be used to identify the levels

of significant human exposure for the

substance and the associated health

effects. The profiles must also include a

determination of whether adequate

information on the health effects of each

substance is available or in the process

of development. When adequate

information is not available, ATSDR, in

cooperation with the National

Toxicology Program (NTP), is required

to assure the initiation of research to

determine these health effects.

Although key studies for each of the

substances were considered during the

profile development process, this

Federal Register notice seeks to solicit

any additional studies, particularly

unpublished data and ongoing studies,

which will be evaluated for possible

addition to the profiles now or in the

future.

The following draft toxicological

profiles will be made available to the

public on or about October 17, 2000.

Document Hazardous substance CAS No.

1 ................................................................ ALDRIN ........................................................................................................................

DIELDRIN .....................................................................................................................

000060–57–1

000309–00–2

2 ................................................................ BERYLLIUM ................................................................................................................. 007440–41–7

3 ................................................................ CREOSOTE .................................................................................................................

COAL TARS .................................................................................................................

COAL TAR PITCH .......................................................................................................

008001–58–9

008007–45–2

065996–93–2

4 ................................................................ DDT ..............................................................................................................................

DDD ..............................................................................................................................

DDE ..............................................................................................................................

000050–29–3

000072–54–8

000072–55–9

5 ................................................................ DI(2-ETHYLHEXYL)PHTHALATE ................................................................................ 000117–81–7

6 ................................................................ HEXACHLOROBENZENE ........................................................................................... 000118–74–1

7 ................................................................ METHOXYCHLOR ....................................................................................................... 000072–43–5

Federal Register / Vol. 65, No. 197 / Wednesday, October 11, 2000 / Notices 60445

All profiles issued as ‘‘Drafts for

Public Comment’’ represent ATSDR’s

best efforts to provide important

toxicological information on priority

hazardous substances. We are seeking

public comments and additional

information which may be used to

supplement these profiles. ATSDR

remains committed to providing a

public comment period for these

documents as a means to best serve

public health and our clients.

Dated: September 25, 2000.

Georgi Jones,

Director, Office of Policy and External Affairs,

Agency for Toxic Substances and Disease

Registry.

[FR Doc. 00–24979 Filed 10–10–00; 8:45 am]

BILLING CODE 4163–70–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

Advisory Committee on Childhood

Lead Poisoning Prevention: Meeting

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(Pub. L. 92–463), the National Center for

Environmental Health (NCEH) of the

Centers for Disease Control and

Prevention (CDC) announces the

following committee meeting.

Name: Advisory Committee on Childhood

Lead Poisoning Prevention.

Times and Dates: 8:30 a.m.–5 p.m.,

October 24, 2000. 8:30 a.m.–12 p.m., October

25, 2000.

Place: Hyatt Regency Crystal City Hotel,

2799 Jefferson Davis Highway, Arlington,

Virginia 22202, telephone 703/418–1234.

Status: Open to the public, limited only by

the space available. The meeting room

accommodates approximately 90 people.

Purpose: The Committee shall provide

advice and guidance to the Secretary; the

Assistant Secretary for Health; and the

Director, CDC, regarding new scientific

knowledge and technological developments

and their practical implications for

childhood lead poisoning prevention efforts.

The Committee shall also review and report

regularly on childhood lead poisoning

prevention practices and recommend

improvements in national childhood lead

poisoning prevention efforts.

Matters To Be Discussed: Agenda items

include: Update on Case Management of

Children with Lead Poisoning issues,

Medicaid issues, Educational,

Environmental, Medical, Developmental, and

Nutritional Management Policy Document

updates, and Impact of Dissemination and

Evaluation of Case Management

Recommendations. Agenda items are subject

to change as priorities dictate.

Opportunities will be provided during the

meeting for oral comments. Depending on the

time available and the number of requests, it

may be necessary to limit the time of each

presenter.

This notice is published less than 15 days

prior to the meeting due to administrative

delay.

Contact Person for More Information:

Becky Wright, Program Analyst, Lead

Poisoning Prevention Branch, Division of

Environmental Hazards and Health Effects,

NCEH, CDC, 1600 Clifton Road, NE, M/S E–

25, Atlanta, Georgia 30333, telephone 404/

639–1789, fax 404/639–2570.

The Director, Management Analysis and

Services Office, has been delegated the

authority to sign Federal Register Notices

pertaining to announcements of meetings and

other committee management activities, for

both the Centers for Disease Control and

Prevention and the Agency for Toxic

Substances and Disease Registry.

Dated: October 4, 2000.

Carolyn J. Russell,

Director, Management Analysis and Services

Office, Centers for Disease Control and

Prevention.

[FR Doc. 00–26135 Filed 10–6–00; 2:43 pm]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

National Vaccine Advisory Committee,

Subcommittee on Future Vaccines,

Subcommittee on Immunization

Coverage, and Subcommittee on

Vaccine Safety and Communication

Meetings

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(P.L. 92–463), the Centers for Disease

Control and Prevention (CDC)

announces the following Federal

advisory committee meetings.

This notice is published less than 15

days prior to the meeting due to

administrative delay.

Name: National Vaccine Advisory

Committee (NVAC).

Times and Dates: 9 a.m.–2:15 p.m.,

October 23, 2000. 8:30 a.m.–3:45 p.m.,

October 24, 2000.

Place: Hubert H. Humphrey Building,

Room 505A, 200 Independence Avenue, SW,

Washington, DC 20201.

Status: Open to the public, limited only by

the space available.

Notice: In the interest of security, the

Department has instituted stringent

procedures for entrance to the Hubert H.

Humphrey Building by non-government

employees. Thus, persons without a

government identification card should plan

to arrive at the building each day either

between 8:00 a.m. and 8:30 a.m. or 12:30

p.m. and 1:00 p.m. Entrance to the meeting

at other times during the day cannot be

assured.

Purpose: This committee advises and

makes recommendations to the Director of

the National Vaccine Program on matters

related to the Program responsibilities.

Matters to be Discussed: Agenda items will

include: a report from the National Vaccine

Program Office (NVPO) and the Interagency

Vaccine Workgroup; an update on the IOM

Report, Vaccines for the 21st Century; an

update on Pandemic Planning; a discussion

of the IOM Report on Immunization Funding;

NVAC Polio Containment Workgroup Report;

Vaccine Safety and Communication

Subcommittee Report; Immunization

Coverage Subcommittee Report; Future

Vaccines Subcommittee Report; update from

the Office of the Assistant Secretary for

Health and Surgeon General; a report on

Global Immunization Initiatives; discussions

on Malaria Vaccine Initiative; a report on HIV

Vaccine Status; Measles Eradication in the

Americas; ACCV Annual Report; VRPBC

Highlights; and ACIP Highlights.

Name: Subcommittee on Future Vaccines.

Time and Date: 2:15 p.m.–5 p.m., October

23, 2000.

Place: Hubert H. Humphrey Building,

Room 305A, 200 Independence Avenue, SW,

Washington, DC 20201.

Status: Open to the public, limited only by

the space available.

Purpose: This subcommittee develops

policy options and guides national activities

that lead to accelerated development,

licensure, and the best use of new vaccines

in the simplest possible immunization

schedules.

Matters to be Discussed: Agenda items will

include discussions on a proposal to hold a

Workshop on Oral Vaccines and an update

on the Workshop on Cytomegalovirus

Vaccine development.

Name: Subcommittee on Immunization

Coverage.

Time and Date: 2:15 p.m.-5 p.m., October

23, 2000.

Place: Hubert H. Humphrey Building,

Room 505A, 200 Independence Avenue, SW,

Washington, DC 20201.

Status: Open to the public, limited only by

the space available.

Purpose: This subcommittee will identify

and propose solutions that provide a

multifaceted and holistic approach to

reducing barriers that result in low

immunization coverage for children.

Matters to be Discussed: Agenda items will

include discussions on adult immunization

standards; the adult immunization action

plan; school-based and other institutional

immunization requirements; and unmet

needs priorities.

Name: Subcommittee on Vaccine Safety

and Communication.

Time and Date: 2:15 p.m.–5 p.m., October

23, 2000.

Place: Hubert H. Humphrey Building,

Room 325A, 200 Independence Avenue, SW,

Washington, DC 20201.

Status: Open to the public, limited only by

the space available.

Purpose: This subcommittee reviews issues

relevant to vaccine safety and adverse

reactions to vaccines.

Matters to be Discussed: Update on

vaccine-related activities; an update on the